Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Trials Regulation and its Impact on Oncology

ESMO-Public-Policy-Webinars-1000x250px-Clinical-Trials

ESMO Public Policy Webinar on the Clinical Trials Regulation and its Impact on Oncology

Date: Tuesday 12 October 2021
Time: 13:00-14:00 CEST

The Clinical Trials Regulation, which was adopted in April 2014 and is foreseen to become applicable in January 2022, will introduce major changes to how clinical trials will be conducted in the EU, aiming to create a more favourable environment for medical research in Europe. Given the importance of this Regulation for research, including clinical trials in oncology, the European Society for Medical Oncology (ESMO) will be convening 2 virtual meetings on this topic, with the first one addressing the implications of the new legislation for medical oncology.

ESMO has been actively engaged in the process leading up to the adoption of the Clinical Trials Regulation and worked towards ensuring that medical oncologists are well informed about the impact of the new Regulation on clinical trials in oncology. Thus, given the implications of the Regulation for medical research in Europe, we feel that it is our responsibility to address this important topic, for the benefit of the oncology and health communities, and most importantly for the patients. 

The 1st webinar – to be held on 12 October 2021 – will address the Clinical Trials Regulation and its impact on oncology, and it will bring together the perspectives of EU officials, clinical researchers, patients and medical oncologists on the Regulation and how it will affect clinical research in oncology.

Speakers include:

  • Rosa Giuliani, European Society for Medical Oncology (ESMO)
  • Peter Arlett, European Medicines Agency (EMA)
  • Stéphanie Kromar, European Organisation for Research and Treatment of Cancer (EORTC)
  • Jan Geissler, PATient adVOCATES (Patvocates)

Register for the webinar here.

The agenda of the meeting can be accessed here. For further information, please do not hesitate to reach out to publicpolicy@esmo.org

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings